pISSN 1226-6051
eISSN 2508-786X

Fig. 1.

Download original image
Fig. 1. Flow chart of the patient population HIRA-NPS, health insurance review and assessment service-national patient sample; CCB, calcium channel blockers; ARB, angiotensin II receptor blockers; DU, diuretics; BB, beta-blockers; ACEI, angiotensin-converting enzyme inhibitors
*There are cases where one person has more than one class duplication, so Total N is less than the sum of people who have prescribed class duplication.
Korean J Clin Pharm 2022;32:125-32 https://doi.org/10.24304/kjcp.2022.32.2.125
© 2022 Korean J Clin Pharm